Gonda, Xenia http://orcid.org/0000-0001-9015-4203
Sarginson, Jane http://orcid.org/0000-0002-0576-4179
Eszlari, Nora
Petschner, Peter
Toth, Zoltan G.
Baksa, Daniel
Hullam, Gabor
Anderson, Ian M.
Deakin, J. F. William http://orcid.org/0000-0002-2750-962X
Juhasz, Gabriella
Bagdy, Gyorgy
Article History
Received: 18 April 2017
Accepted: 14 September 2017
First Online: 10 October 2017
Competing Interests
: JFWD variously performed consultancy, speaking engagements, and research for Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Schering Plough, Janssen-Cilag, and Servier (all fees are paid to the University of Manchester to reimburse them for the time taken); he has share options in P1vital. IMA has received consultancy fees from Servier, Alkermes, Lundbeck/Otsuka and Janssen, an honorarium for speaking from Lundbeck and grant support from Servier and AstraZeneca. All other authors report no financial relationships with commercial interests.